Výsledky vyhledávání - "Hadjiaggelidou, C."

Report

A rare case of autoimmune hemolytic anemia during venetoclax therapy for relapsed chronic lymphocytic leukemia.

Autor: Hadjiaggelidou C; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Douganiotis G; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Tsirou K; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Verrou E; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Triantafyllou T; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Keramidioti K; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Konstantinidou P; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece., Katodritou E; Hematology Department, Theageneio Cancer Hospital of Thessaloniki, Thessaloniki, Greece.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (12), pp. 3054-3056. Date of Electronic Publication: 2021 Jun 21.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment.

Autor: Hadjiaggelidou C; Department of Hematology, Theagenio Cancer Hospital, 54639 Thessaloniki, Greece., Katodritou E; Department of Hematology, Theagenio Cancer Hospital, 54639 Thessaloniki, Greece.

Publikováno v: Journal of clinical medicine [J Clin Med] 2021 Oct 05; Vol. 10 (19). Date of Electronic Publication: 2021 Oct 05.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

A Phase II, Open-Label Study of Lenalidomide and Dexamethasone Followed by Donor Lymphocyte Infusions in Relapsed Multiple Myeloma Following Upfront Allogeneic Stem Cell Transplant.

Autor: LeBlanc, Richard^1,2,3 (AUTHOR) richard.leblanc.1@umontreal.ca, Thiant, Stéphanie² (AUTHOR), Terra, Rafik^1,3 (AUTHOR) rterra.hmr@ssss.gouv.qc.ca, Ahmad, Imran^1,2,3 (AUTHOR) imran.ahmad.1@umontreal.ca, Claveau, Jean-Sébastien^1,2,3 (AUTHOR) js.delisle@umontreal.ca, Bambace, Nadia^1,2,3 (AUTHOR) silvy.lachance@umontreal.ca, Bernard, Léa^1,2,3 (AUTHOR) thomas.kiss@umontreal.ca, Cohen, Sandra^1,2,3 (AUTHOR) denis-claude.roy@umontreal.ca, Delisle, Jean-Sébastien^1,2,3 (AUTHOR) guy.sauvageau@umontreal.ca, Lachance, Silvy^1,2,3 (AUTHOR), Kiss, Thomas^1,2,3 (AUTHOR), Roy, Denis-Claude^1,2,3 (AUTHOR), Sauvageau, Guy^1,3 (AUTHOR), Roy, Jean^1,2,3 (AUTHOR) jean.roy.1@umontreal.ca

Publikováno v: Current Oncology. Nov2024, Vol. 31 Issue 11, p7258-7274. 17p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Autor: Katodritou, E. Terpos, E. Kastritis, E. Delimpasis, S. Symeonidis, A.S. Repousis, P. Kyrtsonis, M.-C. Vadikolia, C. Michalis, E. Polychronidou, G. Michael, M. Papadaki, S. Papathanasiou, M. Kokoviadou, K. Kioumi, A. Vlachaki, E. Hadjiaggelidou, C. Kouraklis, A. Patsias, I. Gavriatopoulou, M. Kotsopoulou, M. Verrou, E. Gastari, V. Christoulas, D. Giannopoulou, E. Pouli, A. Konstantinidou, P. Anagnostopoulos, A. Dimopoulos, M.-A.

Involvement of the central nervous system (CNS) is a rare complication of multiple myeloma (MM). Herein, we have described the incidence, characteristics, prognostic factors for post CNS-MM survival, and outcome of CNS-MM and explored the efficacy of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::cdc5be753c1ee2a5093c8946278673ff
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3124842

Zobrazit plný text záznamu

Report

Visceral Leishmaniasis in 2 Patients Treated With Lenalidomide and Dexamethasone: A Possible Correlation With Blunted Immune Response.

Autor: Hadjiaggelidou C; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Vadikolia C; Hematology Department, 424 Military Hospital, Thessaloniki, Greece., Verrou E; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Yiannaki E; Hematology Lab, Theagenion Cancer Hospital, Thessaloniki, Greece., Triantafyllou T; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Palaska V; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Keramidioti K; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Tsirou K; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Papanikolaou A; Department of Hemopathology, Evangelismos General Hospital, Athens, Greece., Markala D; Hematology Lab, Theagenion Cancer Hospital, Thessaloniki, Greece., Konstantinidou P; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece., Katodritou E; Hematology Department, Theagenion Cancer Hospital, Thessaloniki, Greece.

Publikováno v: HemaSphere [Hemasphere] 2020 Dec 09; Vol. 5 (1), pp. e506. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2021).

Zobrazit plný text záznamu

Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: A report of the Greek myeloma study group in 97 patients

Autor: Katodritou, E. Terpos, E. Symeonidis, A.S. Pouli, A. Kelaidi, C. Kyrtsonis, M.-C. Kotsopoulou, M. Delimpasi, S. Christoforidou, A. Giannakoulas, N. Viniou, N.-A. Stefanoudaki, E. Hadjiaggelidou, C. Christoulas, D. Verrou, E. Gastari, V. Papadaki, S. Polychronidou, G. Papadopoulou, A. Giannopoulou, E. Kastritis, E. Kouraklis, A. Konstantinidou, P. Anagnostopoulos, A. Zervas, K. Dimopoulos, M.A.

Solitary plasmacytoma (SP) is a rare plasma cell dyscrasia characterized by the presence of bone or extramedullary plasma cell tumors. The treatment of choice is local radiotherapy (R/T)±surgical excision. The role of adjuvant chemotherapy (C/T) or

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::24fcb027eb84821da1409db1058c2337
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3127175

Zobrazit plný text záznamu

Akademický článek

Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome.

Autor: Hadjiaggelidou C; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece. chadjiaggelidou@yahoo.com., Mandala E; Fourth Department of Internal Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece., Terpos E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Yiannaki E; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Markala D; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Triantafyllou T; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Papatheodorou A; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Gkastari V; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Verrou E; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Papanikolaou A; Hematopathology Department, Evangelismos General Hospital, Athens, Greece., Konstantinidou P; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece., Katodritou E; Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece.

Publikováno v: Annals of hematology [Ann Hematol] 2019 Jun; Vol. 98 (6), pp. 1457-1466. Date of Electronic Publication: 2019 Mar 20.

Zobrazit plný text záznamu

Akademický článek

Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?

Autor: Katodritou, E., Gastari, V., Verrou, E., Hadjiaggelidou, C., Varthaliti, M., Georgiadou, S., Laschos, K., Xirou, P., Yiannaki, E., Constantinou, N., Markala, D., Zervas, K.

Publikováno v: In Leukemia Research 2009 33(8):1137-1140

Zobrazit plný text záznamu

Akademický článek

Treg-derived TGF-β1 dampens cGAS-STING signaling to downregulate the expression of class I MHC complex in multiple myeloma.

Autor: Zhang, Disi¹ (AUTHOR), Zhan, Dong² (AUTHOR), Zhang, Rui¹ (AUTHOR), Sun, Yunyan¹ (AUTHOR), Duan, Ci¹ (AUTHOR), Yang, Jiapeng³ (AUTHOR), Wei, Jia¹ (AUTHOR), Li, Xianshi¹ (AUTHOR), Lu, Yanqi¹ (AUTHOR), Lai, Xun¹ (AUTHOR) laixun2021@163.com

Publikováno v: Scientific Reports. 5/21/2024, Vol. 11 Issue 1, p1-11. 11p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání